Literature DB >> 31476755

General Anesthesia Management for Adult Mucopolysaccharidosis Patients Undergoing Major Spine Surgery.

Masahiko Tsuchiya1, Hidetomi Terai2, Koh Mizutani3, Yusuke Funai4, Katsuaki Tanaka4, Tokuhiro Yamada4, Takashi Mori4, Kiyonobu Nishikawa4.   

Abstract

OBJECTIVE: Mucopolysaccharidosis (MPS) are a group of rare systemic lysosomal storage diseases associated with severe airway obstruction and cardiac disease, making anesthesia management difficult. Contemporary treatment extends the lifespan of affected individuals, increasing the need for major surgery in adulthood. CLINICAL PRESENTATION AND INTERVENTION: We provided general anesthesia for 6 adult MPS patients undergoing spine surgery. The airway was assessed as difficult in all, with 2 receiving awake fiberoptic intubation and 1 successfully undergoing video-laryngoscopy, while 3 video-laryngoscopy procedures failed and required conversion to fiberoptic intubation. One patient developed ventricular fibrillation.
CONCLUSION: Adult MPS patients have substantial anesthesia risk.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Airway management; Fiberoptic intubation; General anesthesia; Mucopolysaccharidosis; Spine surgery; Video-laryngoscope

Mesh:

Year:  2019        PMID: 31476755      PMCID: PMC6944923          DOI: 10.1159/000503051

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  9 in total

1.  Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome.

Authors:  Elizabeth Braunlin; Shannon Mackey-Bojack; Angela Panoskaltsis-Mortari; James M Berry; Ron T McElmurry; Megan Riddle; Li-Yan Sun; Lorne A Clarke; Jakub Tolar; Bruce R Blazar
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

2.  Fiberoptic intubation through an I-gel supraglottic airway in two patients with predicted difficult airway and intellectual disability.

Authors:  Pavel Michalek; Philip Hodgkinson; William Donaldson
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

Review 3.  Anesthesia for patients with mucopolysaccharidoses: Comprehensive review of the literature with emphasis on airway management.

Authors:  Brittney M Clark; Juraj Sprung; Toby N Weingarten; Mary E Warner
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

Review 4.  Therapies for the bone in mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Adriana M Montaño; Hiromasa Yabe; Akemi Tanaka; Vu Chi Dung; Roberto Giugliani; Francyne Kubaski; Robert W Mason; Eriko Yasuda; Kazuki Sawamoto; William Mackenzie; Yasuyuki Suzuki; Kenji E Orii; Luis A Barrera; William S Sly; Tadao Orii
Journal:  Mol Genet Metab       Date:  2014-12-09       Impact factor: 4.797

5.  Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.

Authors:  C Peters; E G Shapiro; J Anderson; P J Henslee-Downey; M R Klemperer; M J Cowan; E F Saunders; P A deAlarcon; C Twist; J B Nachman; G A Hale; R E Harris; M K Rozans; J Kurtzberg; G H Grayson; T E Williams; C Lenarsky; J E Wagner; W Krivit
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

Review 6.  Surgical management of neurological manifestations of mucopolysaccharidosis disorders.

Authors:  Tord D Alden; Hernán Amartino; Amauri Dalla Corte; Christina Lampe; Paul R Harmatz; Leonardo Vedolin
Journal:  Mol Genet Metab       Date:  2017-09-28       Impact factor: 4.797

7.  Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

Authors:  James E Wraith; Lorne A Clarke; Michael Beck; Edwin H Kolodny; Gregory M Pastores; Joseph Muenzer; David M Rapoport; Kenneth I Berger; Stuart J Swiedler; Emil D Kakkis; Tanja Braakman; Elenie Chadbourne; Karen Walton-Bowen; Gerald F Cox
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

Review 8.  Anesthesiological risks in mucopolysaccharidoses.

Authors:  Alessandra Moretto; Maria Grazia Bosatra; Laura Marchesini; Simonetta Tesoro
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

9.  Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

Authors:  O I I Soliman; R G M Timmermans; A Nemes; W B Vletter; J H P Wilson; F J ten Cate; M L Geleijnse
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

  9 in total
  2 in total

Review 1.  Basic points to consider regarding the preparation of extracellular vesicles and their clinical applications in Japan.

Authors:  Atsunori Tsuchiya; Shuji Terai; Ikki Horiguchi; Yasuhiro Homma; Atsuhiro Saito; Norimasa Nakamura; Yoji Sato; Takahiro Ochiya; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2022-05-19       Impact factor: 3.651

Review 2.  Surgical Management of Spinal Disorders in People with Mucopolysaccharidoses.

Authors:  Hidetomi Terai; Hiroaki Nakamura
Journal:  Int J Mol Sci       Date:  2020-02-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.